Test product,Reference product
Sponsors
Pharmaland(1982) Co.,Ltd., IBS, International Bio Service Co., Ltd, The medicpharma co.,ltd
Conditions
HealthyHealthy Volunteertype 2 diabetes
Sitagliptin phosphate monohydrate
Type 2 diabetes
DPP-A inhibitor
Phase 1
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Dutasteride 0.5 mg Capsules (Dutride, Cyndea Pharma S.L., Spain) and Reference Product (AVODARTâ„¢, GlaxoSmithKline Pharmaceuticals S.A., Republic of Poland) in Healthy Thai Male Volunteers under Fasting Conditions
Active, not recruitingTCTR20180302009
Start: 2018-05-01Target: 32Updated: 2026-03-30
A single dose, randomized, open-label, two-way crossover Bioequivalence study of Duloxetine delayed release capsules USP 60 mg relative to Cymbalta® (60 mg hard gastro-resistant capsules duloxetine) in healthy Thai volunteers under fasting and fed conditions
Active, not recruitingTCTR20200313007
Start: 2020-06-01Target: 32Updated: 2026-03-30